Agne Paner, MD (CME Course Director)
Assistant Professor of Medicine at Rush University Medical Center,
Division of Hematology/Oncology and Stem Cell Transplant
Director, Coleman Foundation Comprehensive Multiple Myeloma Clinic
Rush University Medical Center
Chicago, IL

Agne Paner, MD has disclosed having the following financial arrangements or affiliations with the commercial interests listed below whose products or services may be mentioned in this activity.
Advisory Board: Takeda Oncology
Member, Speakers’ Bureau: Celgene, Onyx/Amgen
Consultant: Takeda Oncology

Kimberly Lynch
PleXus Communications
Kim Lynch has reported having no financial arrangements or affiliations with any commercial interest(s) whose products or services may be mentioned in this activity.

Michaela Ryan, PhD
PleXus Communications
Michaela Ryan, PhD has reported having no financial arrangements or affiliations with any commercial interest(s) whose products or services may be mentioned in this activity.

Accredited By

Co-provided By

This activity is co-provided by Rush University and PleXus Communications.

Activity Details

Credit Type: AMA, ANCC, CPE
Credit Amount: 1.5
Release Date: February 28, 2017
Expiration Date: February 27, 2018
Estimated Time to Complete Activity: 90 minutes
Registration Required: No
Fee for Activity: None

Activity Description

Summary from the 2016 Chicago Multiple Myeloma Rounds Series

Goals (Purpose) of Program

To provide learners with a greater ability to formulate optimal evidence based strategies for the individualized treatment of their patients with multiple myeloma.

Learning Objectives

At the completion of the four (4) available modules, participants should be able to:

  • Evaluate the biologic and molecular mechanisms involved in the pathology of multiple myeloma and their potential as therapeutic targets and predictors of outcomes
  • Assess finalized and ongoing clinical trial data utilizing standard of care and/or investigational therapies that have the potential to enhance clinical outcomes in newly diagnosed and relapsed/refractory multiple myeloma
  • Recognize disease and therapy associated adverse events and formulate strategies for their management
  • Formulate optimal evidence-based strategies for the individualized treatment of multiple myeloma that take into consideration patient risk factors

Target Audience

This activity is designed to meet the needs of healthcare professionals involved in the treatment of patients with multiple myeloma.

Requirements for Successful Completion

In order to receive credit for participating in this program, participants must listen to the program in its entirety and then complete and submit the CME/CE evaluation form at the conclusion of the program.

Conflict of Interest Policy / Disclosure Statement

Rush University and Plexus Communications ensure balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, Rush University identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Rush University to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Rush University is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Accreditation Statement

Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

Rush University Medical Center designates this enduring activity for a maximum of one and a half (1.5) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this enduring activity for one and a half (1.5) Continuing Education credits. This activity will fulfill Category 1 contact hour requirements for pharmacology for ANCC certified advanced practice nurses. 

This program is approved for 1.5 hours (1.5 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks for participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
UPN #: 0761-9999-16-017-L01-P

Instructions for Receiving Credit

Participants must complete and submit the online CE evaluation form at the conclusion of the activity and achieve a passing score of 75% or better. Certificates will be generated upon completion and submission of the evaluation form.

Statement of Commercial Support

This activity is supported by educational grants provided by AbbVie Inc., Adaptive Biotechnologies, Celgene, Janssen Biotech, Spectrum Pharmaceuticals, and Takeda Oncology.

Disclaimer Statement

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Rush University, PleXus Communications, and/or the commercial supporters. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Rush University, PleXus Communications and/or the commercial supporters. Rush University’s ANCC accreditation status does not imply endorsement by Rush or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Contact Information for Questions about the Activity

Hardware / Software Requirements

OpenCME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.